Stefan Bornstein, MD: Diabetic Patients During COVID-19

December 4, 2020
Kenny Walter

Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

Strategic Alliance Partnership | <b>The Metabolic Institute of America</b>

Diabetic patients are more susceptible to severe COVID-19 outcomes.

Diabetic patients need to be particularly careful during the coronavirus disease 2019 (COVID-19) pandemic.

These patients have become particularly susceptible to suffering from more severe outcomes should they contract the virus.

While there is hope for that more protections in the form of vaccines could be on the way, there is still a need to do a better job of protecting this patient population.

In an interview with HCPLive® Stefan Bornstein, MD, Professor of Endocrinology, Metabolism, and Diabetes at the Technical University at Dresden, explained what researchers have learned about the interaction between the COVID-19 virus and diabetic patients and what the best practices are for treating these patients.

Bornstein presented new data during the 18th World Congress of Insulin Resistance Diabetes & Cardiovascular (WCIRDC) Online CME Conference, sponsored by the Metabolic Institute of America (TMIOA).

Bornstein’s presentation focuses on the severity of the viral infections and hyperglycemia and uncontrolled diabetes. He explained it is still unknown why there is such an association between this patient population and COVID-19 outcomes.

He also said there needs to be better ways to treat the severely ill patients once they are admitted into the hospital.